Skip to main content
Critique of Bombay HC's Ruling in Jyothy Labs v. Dabur
Back to Court News
Bombay High Courtintellectual_property

Critique of Bombay HC's Ruling in Jyothy Labs v. Dabur

September 9, 2026

A critical analysis reveals potential doctrinal issues in the Bombay HC's decision on the NEEM trademark case, questioning the court's legal reasoning.

Critical Analysis of Bombay High Court's Decision in Jyothy Labs v. Dabur

The case of Jyothy Labs v. Dabur presents a unique viewpoint on trademark law, specifically regarding the usage of the term 'NEEM' on toothpaste packaging. Upon closer examination, the Bombay High Court's decision, while seemingly straightforward, is fraught with doctrinal inconsistencies.

The core issues include the court's approach to essential-feature protection, the descriptive versus suggestive divide, and the application of passing off principles. While the outcome may be favorable based on the facts, the underlying legal reasoning raises significant concerns about its durability in future cases.

Legal professionals, particularly those engaged in trademark disputes, should reflect on this ruling as it poses critical questions about the coherence of judicial reasoning in trademark jurisprudence and its potential implications for similar cases in the future.

Citations

  • Jyothy Labs v. Dabur (2026) Bombay HC
Practice Areas:intellectual_property

Related Articles

View All →
ANI v. OpenAI: Landmark Ruling on AI and Copyright in IndiaFeatured
Delhi High Courtintellectual_propertyconstitutional

ANI v. OpenAI: Landmark Ruling on AI and Copyright in India

The Delhi High Court's interim order in ANI v. OpenAI marks a pivotal moment in Indian copyright law as it recognizes user rights and fair dealing principles in the context of AI use.

Aug 4, 2026Read more →
Delhi HC Rules No Declaration Needed Under Section 11(2)Featured
Delhi High Courtintellectual_property

Delhi HC Rules No Declaration Needed Under Section 11(2)

The Delhi High Court in ZARA v. ZORA held that a formal declaration of well-known status under Rule 124 is not mandatory to invoke Section 11(2) protections. The ruling enables litigants to establish well-known status through evidence in individual cases.

Oct 3, 2026Read more →
Critique of IPO’s 2026 Draft Pharma Patent GuidelinesFeatured
Indian Patent Office (Administrative Guidelines)intellectual_propertypharmaceutical

Critique of IPO’s 2026 Draft Pharma Patent Guidelines

IPO’s Draft Guidelines for Examination of Pharmaceutical Patent Applications, 2026, face sharp criticism for misquoting statutory provisions and misinterpreting Section 3(d) of the Patents Act. Experts warn the draft could undermine patent stability and prosecution consistency if adopted without revision.

Sep 29, 2026Read more →
Critique of Bombay HC's Ruling in Jyothy Labs v. Dabur | Gatim AI Court News | Gatim AI